HOME >> MEDICINE >> NEWS
Cholesterol-lowering drugs reduce risk of stroke, heart attack

BOSTON -- People whose cholesterol improved after one month on cholesterol-lowering drugs called statins reduced their risk of stroke and heart attack, according to research that will be presented at the American Academy of Neurologys 59th Annual Meeting in Boston, April 28 May 5, 2007.

The study enrolled 4,731 people within one to six months of having a stroke or transient ischemic attack, or mini-stroke, and with no history of heart disease. Half of the participants received the cholesterol-lowering drug atorvastatin and half received a placebo. The participants were then followed for an average of four and a half years.

For each 10-percent decrease in LDL, or low-density lipoprotein bad cholesterol, the risk of stroke was reduced by four percent and the risk of heart attack was reduced by seven percent. The average decrease in LDL cholesterol after one month on atorvastatin was 53 percent.

These findings reinforce the importance of controlling cholesterol, said study author Pierre Amarenco, MD, of Denis Diderot University in Paris, France, and Fellow member of the American Academy of Neurology. Its encouraging to see that reducing cholesterol so quickly can have positive long-term effects.

People with higher levels of HDL, or high-density lipoprotein good cholesterol, at the beginning of the study and after one month had a lower risk of stroke.


'"/>

Contact: Angela Babb
ababb@aan.com
651-695-2789
American Academy of Neurology
2-May-2007


Page: 1

Related medicine news :

1. Cholesterol-lowering drugs may be useful in an influenza pandemic
2. Cholesterol-lowering drugs not associated with increased breast cancer risk
3. UIC researchers to develop new drugs to fight bioterrorism
4. Statin drugs may delay progressive artery damage in children
5. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
6. Experts call for urgent research into anti-epileptic drugs given to children
7. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
8. Antipsychotic drugs increase risk of death in older people with dementia
9. Antipsychotic drugs increase risk of death in older people with dementia
10. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients
11. Panel offers guidelines on skin reactions to new class of cancer drugs

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cholesterol lowering drugs reduce risk stroke heart attack

(Date:10/31/2014)... 31, 2014 At the start of ... narrowly escaping carbon monoxide poisoning in their homes. Now, ... away, one family-owned, Missouri-based heating and cooling company is ... sure families start the home heating season with the ... , Beginning Nov. 1, 2014, E and Q ...
(Date:10/31/2014)... UT (PRWEB) October 31, 2014 ... new Activz Silver line offering natural silver ... wipes. For over a century, silver has been used ... in Activz Silver products is the most advanced version ... has a unique chemical structure that supports the existing ...
(Date:10/31/2014)... 2014 (HealthDay News) -- Surgery for low back pain ... the United States you live, a new report says. ... back pain at some point in their lives, and ... care for a spine problem," co-author Brook Martin, of ... said in a college news release. In spinal ...
(Date:10/31/2014)... News) -- Obesity increases the risk of certain types ... two new U.S. studies show. One study of ... obese increased the risk for estrogen receptor-negative and progesterone ... this for a long time for white women, but ... study author Esther John, a senior research scientist at ...
(Date:10/31/2014)... insomnia is a major contributor to deaths caused by ... results underscore the importance of the "Sleep Well, Be ... , Results show that the risk of unintentional fatal ... of insomnia symptoms present. People with all three symptoms ... from a fatal injury than those with no insomnia ...
Breaking Medicine News(10 mins):Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 4Health News:Spinal Surgery Varies by Region in U.S.: Study 2Health News:Study Confirms Obesity-Breast Cancer Link for Blacks, Hispanics 2Health News:Insomnia increases risk of motor vehicle deaths, other fatal injuries 2
(Date:10/31/2014)... Oramed Pharmaceuticals Inc. (NASDAQCM: ... on the development of oral drug delivery systems, ... call to discuss the clinical results from its ... proprietary oral insulin capsules, to treat type 1 ... a.m. Eastern time. Shareholders and other ...
(Date:10/31/2014)... announces the list of stocks featured in the Analyst Blog. Every ... events impacting stocks and the financial markets. Stocks recently featured in ... Report ), Celgene (Nasdaq: CELG - Free Report ... ), Market Vectors Biotech ETF (AMEX: BBH - ... XBI - Free Report ). Today, Zacks is ...
(Date:10/31/2014)... , October 31, 2014 Multigate Medical ... patents of B. Braun Melsungen AG (B. Braun) by selling ... safety IV catheters manufactured by Poly Medicure Ltd (Polymed). The ... proceeding number VID 463 of 2013 can be ... detailed judgment, Multigate was found to have infringed claim 1 ...
Breaking Medicine Technology:Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 2The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 4The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 5The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 6The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 7B. Braun Wins Patent Disputes Against Poly Medicure Ltd's Australian Distributor Multigate Medical Devices Pty. Ltd. and Spanish Distributor Dextromédica S. L. 2
Cached News: